What Azento Health is all about

Modern weight loss is changing fast. GLP-1 and anti-obesity medicines are powerful, but patients need better support around gut health, tolerability, nutrition routines and long-term wellbeing. Azento Health develops science-based companion products for that journey.

Science
Science

We translate microbiome science into practical companion products for people navigating obesity care and modern weight-loss treatments.

Care
Care

Our products are designed to fit into real daily routines – supporting gut health, digestive comfort and better continuity along the treatment journey.

Health & Happiness
Health & Happiness

We believe weight management is not only about kilograms lost, but about helping people feel better, live better and stay supported over time. It is about Health and Happiness.

Manufactured in Europe. Built for modern weight management.

Shaping the future of obesity care

Modern Obesity Treatments are changing the weight-loss landscape. Over the last few years, GLP-1 and next-generation anti-obesity medicines have moved from specialist care into a global health mega trend – and this category is expected to grow significantly in the coming years.

At Azento Health, we are building a portfolio of microbiome-based companion solutions to support people before, during, and after anti-obesity medication treatment – addressing key needs in gut health, digestive comfort, nutrition routines and long-term wellbeing.

The Market Opportunity

1B+
adults are projected to live with obesity by 2030 - making obesity one of the largest unmet needs in global health.
$105–200B
projected global obesity medicines market opportunity from 2027 and beyond projected by IQVIA
Up to 70%
of patients on GLP-1 therapies experience gastrointestinal side effects, creating a clear need for companion support.
The Challenge

As Modern Obesity Treatments continue to expand, a new companion products category is emerging around gut health, digestive comfort, nutrition, hydration, muscle preservation and long-term weight maintenance.

Read More

Driven by research and science

The Challenge

The microbiome active foundation

Bifidobacterium animalis ssp. lactis AZHx1

DSMZ patent deposit ID: DSM 35201

azh-biotics®

Lactobacillus (Limosilactobacillus) reuteri AZHx2

DSMZ patent deposit ID: DSM 35202

azh-biotics®

Lactobacillus (Lacticaseibacillus) casei AZHx3

DSMZ patent deposit ID: DSM 35185

azh-biotics®

Lactobacillus Lacticaseibacillus rhamnosus GG AZHx4

DSMZ patent deposit ID: DSM 33795

azh-biotics®

DSMZ-German Collection of Microorganisms and Cell Cultures GmbH